Warning Letters Sent to Companies Illegally Selling OTC Skin Lightening Products
These OTC skin lightening products containing the active ingredient hydroquinone are not approved and are not generally recognized as safe and effective.
Pigmentation Disorders
Cases Detail Leukomelanoderma Following Topical Skin Cream Use
Two cases documented in patients taking hydroquinone at a concentration of 7 to 10 percent
Confetti-Like Depigmentation May Predict Vitiligo Progression
Confetti-like depigmentation may be a marker of rapidly progressing vitiligo.
RA Drug May Also Help Ease Vitiligo
Researchers report that a drug for rheumatoid arthritis may be a promising treatment for vitiligo.
Atopic Dermatitis Greater Among Vitiligo, Alopecia Areata Patients
The prevalence of atopic dermatitis (AD) is higher among patients with vitiligo or alopecia areata (AA), according to new research.
Cosmetic Camouflage Benefits Youth With Vascular, Pigmentary Issues
Cosmetic camouflage can improve quality of life in children and adolescents with visible vascular and pigmentary anomalies.
Teledermatology Is Reliable for Initial Triage Consultations
Teledermatology is reliable for initial triage of patients, according to a study published online.
Botanical Extracts May Aid in Lightening Hyperpigmentation
Botanical extracts may be helpful in the treatment of hyperpigmentation, although identification of hyperpigmentation subtype may be important for treatment prognosis.
3D Imaging Captures Changes in Port Wine Stains
Three-dimensional (3D) high precision surface imaging can be used to monitor changes in the area and volume of port wine stains following laser treatment.
Tri-Luma Cream Available Again for Melasma
Galderma announced that Tri-Luma (fluocinolone acetonide 0.01%, hydroquinone 4%, tretinoin 0.05%) cream is available again for short-term treatment (up to 8 weeks) of moderate to severe melasma of the face, in the presence of measures for sun avoidance, including the use of sunscreens.
